Luca Roncati

Luca Roncati, Italian pathologist, physician-scientist, anti-cancer patent inventor, academic editor, medical lecturer, and award-winning author with more than 260 publications to his credit, specialized in gynaecologic oncology, paediatric pathology, hematopathology and soft tissue tumours, eponym of Roncati-Manenti triad, describer of T rex lymphoma, pioneering researcher in COVID-19, leading researcher in nanopathology, forensics expert and adjunct professor of Anatomical Pathology at the University of Modena and Reggio Emilia (Italy).

Kiokias Sotirios

Dr Sotirios Kiokias is a PhD in the area of Food Chemistry and Nutrition (University of Reading/UK). In his early career (2002-2006) he performed EU funded postdoctoral research at Unilever R&D (The Netherlands) and National Technical University of Athens. In the period 2006-2016 he was employed as scientific expert by various EU Institutions (DG Enterprise & European Chemicals Agency/Finland). Since 2017, Dr Kiokias is a Research Program manager at the European Research Executive Agency of European Commission (Brussels), serving as the Coordinator of Chemistry Panel in MSCA-Staff exchanges Action. Dr Kiokias has published more than 40 scientific publications in international journals/book chapters and participated in a large number of International Food & Chemistry relevant Conferences

Dr Marco Penske

Dr Marco Penske has been the Head of Market Access and Healthcare Affairs at Boehringer Ingelheim since 2011. Dr Penske studied Economics at Johannes Gutenberg University Mainz, focussing on Health Economics and Statistics. Afterwards, he worked as a research assistant for the chair of Finance and Economics at the university. Following his promotion in the field of healthcare systems, he was employed at a business consultancy company. In 2007, he joined Boehringer Ingelheim and gained experience within several Market Access functions. In his current role, he is responsible for benefit assessments and price negotiation in accordance with AMNOG, developing pricing strategies and contract models for pharmaceuticals, health economics and outcomes research as well as key account management and healthcare affairs activities. In addition, he is an active speaker at congresses and works as a lecturer.

Marià Alemany Lamana

Marià Alemany Lamana (Barcelona, ​​1946) has been professor of nutrition and biochemistry at the Faculty of Biology of the University of Barcelona. He has been an emeritus professor since 2016.

Degree in Biology from the University of Barcelona (1968), where he also obtained a doctorate in Biological Sciences (1972) with the thesis " Algunos aspectos del metabolismo del glucógeno en el mejllón ("Mytilus edulis" L.) ". He did postdoctoral studies (1973-74) at Washington University in St. Louis, in the United States.

Professor at the University of Barcelona (1968-1977), University of the Balearic Islands (1977-1982), University of Barcelona in Tarragona (1982-1986) and once again at the University of Barcelona, ​​where he has been professor at the Faculty of Biology from 1986 until his retirement in 2016. He has also been assistant professor of Physiology (1974), associate (1977) and professor of Biochemistry (1981, 2012), Nutrition (2001).

He has published several technical, lexicographic, essay and dissemination books, as well as fiction.

Ralf Aubeck

Ralph Aubeck works worldwide for Gempex GmbH as Principal Consultant and Industry Certified GMP Auditor. He studied chemistry at the Ludwig-Maximilians-University in Munich and received his PhD in 1991. re. of course via chemical-pharmaceutical biosensors. More than 28 years of experience in responsible positions in quality management in German and American small and medium-sized industrial companies as well as large corporations in Germany and Switzerland form the foundation of his practical expertise.

Dr Orestis Ioannidis

Dr. Ioannidis studied medicine in the Aristotle University of Thessaloniki and graduated at 2005. He received his MSC in “Medical Research Methodology” in 2008 from Aristotle University of Thessaloniki and in “Surgery of Liver, Biliary Tree and Pancreas” from the Democritus University of Thrace in 2016. He received his PhD degree in 2014 from the Aristotle University of Thessaloniki for his thesis “The effect of combined administration of omega-3 and omega-6 fatty acids in ulcerative colitis. Experimental study in rats.” He is a General Surgeon with special interest in laparoscopic surgery and surgical oncology and also in surgical infections, acute care surgery, nutrition and ERAS. He has received fellowships for EAES, ESSO, EPC, ESCP and ACS and has published more than 130 articles with more than 3000 citations and an H-index of 28.

Casten Jasper

Casten Jasper is currently working as a Director, Validations & Systems Operations Europe & Asia at Charles River Laboratories Microbial Solutions. He having 15 years of experience in Biotechnology field. In his current role he is responsible for defining and implementing strategies and processes for GMP-compliant processes and systems at the European Microbial Solutions sites. He also serves as a subject matter expert for internal development projects and is member of various industry communities.

DOĞAN TAŞKENT

After graduating from ETH Zürich with a degree in Electrical Engineering in 1993, Mr. Taskent joined MIT for research and Polytechnic Institute of New York University for the Electrophysics and Technology MBA degrees.

During 1998-2005, he worked as a R&D engineer, expert consultant and instructor at Lucent Technologies Bell Laboratories. During that timeframe he led major fiberoptic transmission system deployments.  During 2006-2007 worked as CTO at the Lucent Technologies Istanbul Office. 2008-2018 worked at Arkan & Ergin Corporate Finance, focusing startup valuation, development of Turkish startup ecosystem and growing the  technology transfer environment.  Since 2019 has been working at Atabay Pharmaceuticals and Fine Chemicals as director responsible for R&D and innovation.  Academically, teaching MBA students on technology and innovation management at Koç University since 2012.

He is the founding President of MIT Enterprise Forum in Turkey, was member at the Advisory Board of the Endeavor Turkey and founding Board member of the Ege University Technopark. He has been Chairman of the Board at the Swiss Chamber of Commerce in Turkey and also the Vice-President at the Foreign Economic Relations Board (DEIK) responsible for Switzerland.

Currently serving as the Board Member at the Global Relations Forum, at the University Industry Relationships Platforms, and at Izmir Biomedicine and Genome Center.

Matthias Angelmaier

Matthias Angelmaier is a Senior Project Engineer and Global Technology Partner for Fill-Finish at Pharmaplan. He joined the company in August 2022.

His previous positions were at a multinational processing and packaging technology solutions provider where he started in 2009 as a project manager for handling complex customer projects. Since 2012 he was global responsible product manager for aseptic fill-finish, barrier and Isolator systems as well as process technology.

His expertise includes process engineering, sterilization, biodecontamination, aseptic and high-potent Isolator applications, GMP and HSE-related fill-finish applications as well as topics related to advanced aseptic processing.

He has a bachelor’s degree in industrial and mechanical engineering as well as a master’s degree in business development.

Miloš Milenković

Mr Miloš Milenković is currently working as a Strategic Partnering Chapter Head & CEETRIS region Established Products Lead at Roche, Serbia. He also worked as a Commercial Affairs Lead in Turkey, Strategic Partnership Lead, Commercial and Partnering, Head Business Development & Commercial Manager in Roche & GlaxoSmithKline (GSK).

He having more than 20 years of experience in Pharma industries. He is graduate in pharmacy & post graduate in MBA from Frankfurt School of Finance and Management, Frankfurt, Germany.

Dr Thomas Webster

Thomas J. Webster’s (H index: 118; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies who have numerous FDA approved medical products currently improving human health.  He is currently helping those companies and serves as a professor at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and others.  Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.  Prof. Webster is a former President of the U.S. Society For Biomaterials and has over 1,350 publications to his credit with over 53,000 citations. He was recently nominated for the Nobel Prize in Chemistry (2023).

Christian Lavarreda

Christian Lavarreda, based out of Dresden, Germany, is currently global product manager for pure media, process, and bioprocess systems at Syntegon (formerly Bosch Packaging Technology). Formally trained as a chemical engineer, he is responsible for leading the development, commercialization, and marketing of Syntegon’s pharmaceutical liquid processing portfolio. Prior roles at Syntegon have also included regional business development and marketing manager for liquid pharmaceutical primary packaging in North America. During his seven years at Syntegon, Christian has utilized his expertise to connect customer needs to Syntegon’s capabilities while helping manage account relationships to ensure customer success and satisfaction. Christian also has a background in inhalable drug product development, where he spent twelve years leading R&D and commercialization activities of analytical instrumentation for the delivered-dose uniformity and particle size characterization of dry powder, metered-dose, nebulizer, and nasal inhalers. He has multiple peer-reviewed publications on the application of cascade impaction technology for the characterization of aerosolized medicines.

Dr Thomas Hauser

Thomas Hauser (*1967) is working since June 2023 for C-CUBE as a Sales Director in the EMEA region to educate the market for offsite prefabricated and prequalified turn-key factory and smart module concept in a drive to bring forward the pharmaceutical facility of the future concept.

In his former work for G-CON and his consulting agency, he has supported companies in the life science segment mainly for expansion strategies, strategical facility implementation, start-up support and pharmaceutical packaging supply and technologies, in particular in questions of manufacturing set-up.

Before 2020, Thomas worked in various leading global positions in Business Development, Strategic Implementation and Sales in the Pharmaceutical Packaging field, namely in injectables, semi solid and oral solid packaging. He has more than 25 years of experience dealing with the global Lifesciences Industry and their market and manufacturing requirements.

Thomas holds an International MBA from the University of Ottawa / Canada, and a BA for European Business from the ESB Reutlingen and the ESC Reims.